Ipas partners with DKT International to expand access to safe abortion in 100+ countries
Ipas and DKT International announced this month an exclusive partnership in which the Ipas Manual Vacuum Aspiration (MVA) technology will be licensed to DKT for global distribution, furthering their joint mission of providing safe and high-quality family planning and abortion care for the estimated 56 million women worldwide who choose to have an abortion each year. Formerly, distribution of the Ipas MVA technology was overseen by WomanCare Global.
In an effort to expand global access to safe abortion care, particularly for women in low- and middle-income countries, the partnership will leverage the respective strengths of Ipas and DKT.
The Ipas MVA kit is used in over 100 countries, including the U.S., and is the world’s most utilized, safe and effective surgical abortion technology. DKT is one of the largest providers of family planning services in the developing world, with programming in more than 35 countries that contain approximately 65 percent of the world’s people. DKT expands access to abortion care by ensuring abortion-related products and technologies are widely available, and implementing education and outreach campaigns that reach women, especially in poor and rural areas.
“We look forward to expanding on the great work of Ipas and WomanCare Global, which have provided over one million reusable MVA kits and served more than 32 million women since 2009,” says Christopher Purdy, President and CEO of DKT International. “While DKT will handle all manufacturing, distribution, marketing and regulatory oversight of MVA kits, Ipas will retain the training and education programs for providers and the public, creating an environment conducive to administering the technology to the women who need it most.”
For more information, contact firstname.lastname@example.org